Worldwide Healthcare Trust (WWH)
market vs.
industry GROWTH & VALUE
| Trailing 12m | ||||
| PE Ratio (ttm) | 5.68 |
|
|
|
| PEG Ratio (ttm) |
|
|
||
| EPS Growth (ttm) | % |
|
|
|
| Dividend Yield (ttm) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 1.23 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Mar | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | TTM | 2013E | 2014E | CAGR / Avg | |
| Revenue | £m | ||||||||||
| Operating Profit | £m | ||||||||||
| Net Profit | £m | ||||||||||
| EPS Reported | p | ||||||||||
| EPS Normalised | p | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | p | ||||||||||
| Capex ps | p | ||||||||||
| Free Cashflow ps | p | ||||||||||
| Last ex-div: 5th Jun, paid: 5th Jul more... Dividends | |||||||||||
| Dividend ps | p | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | £m | ||||||||||
| Working Capital | £m | ||||||||||
| Net Fixed Assets | £m | ||||||||||
| Net Debt | £m | ||||||||||
| Book Value | £m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | p | +11.8% | |||||||||
FINANCIAL BRIEF: For the six months ended 30 September 2012, Worldwide Healthcare Trust PLC revenues increased from -L4.9M to L29.9M. Net income totaled L27.4M vs. loss of L8.2M. Revenues reflect Gains on Investments increase from -L7M to L25.8M, Exchange Gain on Currency Balances increase of 73% to -L587K, Income increase of 10% to L4.7M. Net Income reflects Finance charges decrease of 22% to L137K (expense). Dividend per share totaled to L0.07. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 30th Sep '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 1 | 0 | 1 | 0 |
Worldwide Healthcare Trust PLC, formerly Finsbury Worldwide Pharmaceutical Trust PLC, is an investment trust. The Company invests worldwide in pharmaceutical and biotechnology companies and related securities in the healthcare sector with the objective of achieving a high level of capital growth. As of March 31, 2012, the Company’s investment portfolio included equities (including options and swaps), convertibles and fixed interest securities. As of March 31, 2012, its top 10 investments included Life Technologies, Allergan, Wellpoint, Incyte Corp, Bristol-Myers Squibb, Dendreon, GlaxoSmithKline, Aetna, Elan and Baxter International. Its investment manager is Frostrow Capital LLP.
No Management Information.
No. of Employees: 0 No. of Shareholders: n/a
| Last Annual | March 31st, 2012 |
| Last Interim | September 30th, 2012 |
| Shares in Issue | 45,341,464 |
| Free Float | 42.9m (94.6%) |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | FTSE 350 Act , FTSE Lower Yield , FTSE 250 Mid , FT350 Eq Inv Ist , |
| Exchange |
London Stock Exchange (Full) |
| Eligible for | an ISA? a SIPP? |
| Address | 25 Southampton Buildings, LONDON, WC2A 1AL, United Kingdom |
| Web | http://www.worldwidewh.com |
| Phone | +44 203 0084910 |
| Contact | Ian Ivory (Chmn.,) |
| Registrar | Capita Registrars |
| Auditors | Ernst & Young LLP |
